Invention Grant
US08853157B2 Methods of treating steroid-induced obesity using GLP-1 agonists
有权
使用GLP-1激动剂治疗类固醇诱导的肥胖症的方法
- Patent Title: Methods of treating steroid-induced obesity using GLP-1 agonists
- Patent Title (中): 使用GLP-1激动剂治疗类固醇诱导的肥胖症的方法
-
Application No.: US13776839Application Date: 2013-02-26
-
Publication No.: US08853157B2Publication Date: 2014-10-07
- Inventor: Sanne Moeller Knudsen , Karin Rimvall
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Leon Y. Lum
- Priority: DK200400911 20040611
- Main IPC: A61P3/06
- IPC: A61P3/06 ; A61K38/26 ; A61K31/56 ; A61K38/00 ; A61K31/26
Abstract:
The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
Public/Granted literature
- US20130165370A1 Counteracting Drug-Induced Obesity Using GLP-1 Agonists Public/Granted day:2013-06-27
Information query
